About

Corporate Office

VANCOUVER, B.C. CANADA

Facility Location

SOUTHEAST QUEENSLAND AUSTRALIA

Facility Size

51 HECTARES/125 ACRES

Projected Capacity

537,500 KG/ANNUM

Asterion Cannabis Inc. is a Canadian medicinal cannabis company with a wholly-owned Australian subsidiary, Asterion (Australia) Pty Ltd. With its cultivation to market strategy, the company's focus is leading and advancing cannabis agriculture, producing the highest quality, low cost, genetically uniform cannabis strains and cannabinoid products for global supply. The Australian government formally recognizes the company with a Major Project Status and the company has been granted a medicinal cannabis license, a cannabis research license, and a manufacture license from the Australian Office of Drug Control.

Led by a highly experienced team with over 200 years of combined relevant credentials spanning – North America, Europe, the Middle East, and Asia-Pacific. Management experience with large scale projects includes medicinal cannabis, renewable energy, and capital markets.

  • Finance
  • Corporate Relations
  • International Business Development
  • Pharmaceuticals
  • Nutraceuticals
  • Preventive Health
  • Cannabis/Hemp
  • Commercialization
  • Natural Resources
  • Renewable Energy
  • Industrial Development
  • Multi-jurisdiction Exporting
  • Hi-tech Horticulture
  • State-of-the-art R&D
March 31, 2020

Asterion Signs DAA for $400 Million

arrowRead More
March 9, 2020

Asterion Cannabis to Participate in the 32nd Annual ROTH Conference

arrowRead More
January 24, 2020

Asterion Cannabis Announces Annual General Meeting Results and Election of New Director

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?